Terminated NA INTERVENTIONAL 2-arm NCT00142883

The Effects of GABA Enhancing Medications on Individuals Addicted to Cocaine - 3

The Effects of GABA Medications on Cocaine Responses in Humans

Sponsor: National Institute on Drug Abuse (NIDA)

Conditions Cocaine Abuse Cocaine-Related Disorders

Updated 5 times since 2017 Last updated: Jul 7, 2015 Started: Sep 30, 2004 Primary completion: Sep 30, 2006 Completion: Sep 30, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Terminated

Study has been completed

Other terminated trials from National Institute on Drug Abuse (NIDA)

See all terminations from National Institute on Drug Abuse (NIDA)

Other Cocaine Abuse trials with similar outcome

Browse all Cocaine Abuse trials

Listed as NCT00142883, this NA trial focuses on Cocaine Abuse and Cocaine-Related Disorders and remains terminated or withdrawn. Sponsored by National Institute on Drug Abuse (NIDA), it has been updated 5 times since 2004, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Terminated NA
Jul 2024 — Sep 2024 [monthly]

Terminated NA
Jan 2021 — Jul 2024 [monthly]

Terminated NA
Jun 2018 — Jan 2021 [monthly]

Terminated NA
Jan 2017 — Jun 2018 [monthly]

Terminated NA

First recorded

Sep 2004

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

National Institute on Drug Abuse (NIDA)
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• West Haven, United States